AI Assistant
Blog
Pricing
Log In
Sign Up
ECRG2
enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells
via
upregulation of
p53
and downregulation of
PNCA
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.